{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:35:35Z","timestamp":1786732535910,"version":"build-2736575974"},"update-to":[{"DOI":"10.1371\/journal.pntd.0014642","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000}}],"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Oropouche virus (OROV) is an arbovirus of concern due to its recent geographical expansion and association with teratogenic outcomes. Serodiagnosis of OROV infection relies on methods such as the immunoglobulin M antibody-capture enzyme-linked immunosorbent assay (MAC-ELISA) and the plaque reduction neutralization test (PRNT). For re-emerging viruses such as OROV, sourcing large quantities of sera from acutely infected human donors for use as positive-control assay material is a significant challenge and hinders diagnostic capacity. To overcome this, we engineered and produced OROV119-chIgM, a human-murine chimeric IgM (chIgM) that expresses the variable regions of the murine monoclonal antibody OROV119, reactive to the Gc protein of OROV, on a human IgM backbone. OROV119-chIgM was evaluated in PRNT and MAC-ELISA to determine its suitability as a positive control in each assay. In PRNT, OROV119-chIgM achieved neutralization equivalent to an OROV polyclonal mouse hyperimmune ascitic fluid (MHIAF). Further, OROV119-chIgM exhibited superior performance compared with OROV-positive human donor sera in a MAC-ELISA. Overall, OROV119-chIgM is an attractive alternative to human donor sera assay control material because of its long-term sustainability and consistent batch-to-batch potency. OROV119-chIgM enhances diagnostic capacity by ensuring laboratories are poised to respond rapidly to future OROV outbreaks.<\/jats:p>","DOI":"10.1371\/journal.pntd.0014642","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T17:41:07Z","timestamp":1786383667000},"page":"e0014642","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["An engineered anti-Oropouche virus human-murine chimeric immunoglobulin M is a viable substitute for positive human serum controls in diagnostic serology assays"],"prefix":"10.1371","volume":"20","author":[{"given":"Kerri L.","family":"Miazgowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin H.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8237-2654","authenticated-orcid":true,"given":"Amanda E.","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"pntd.0014642.ref001","unstructured":"Epidemiological Alert - Oropouche in the Americas Region, 11 February 2025. [press release]; 2025."},{"issue":"3","key":"pntd.0014642.ref002","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaf018","article-title":"Travel-associated international spread of Oropouche virus beyond the Amazon","volume":"32","author":"FC de Melo Iani","year":"2025","journal-title":"J Travel Med"},{"issue":"2","key":"pntd.0014642.ref003","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1473-3099(24)00617-0","article-title":"Newborns with microcephaly in Brazil and potential vertical transmission of Oropouche virus: a case series","volume":"25","author":"FE das Neves Martins","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pntd.0014642.ref004","doi-asserted-by":"crossref","first-page":"2603781","DOI":"10.1080\/14767058.2025.2603781","article-title":"Oropouche virus infection in pregnancy: emerging evidence on vertical transmission and perinatal outcomes","volume":"39","author":"A Braga","year":"2026","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"38","key":"pntd.0014642.ref005","article-title":"Oropouche virus efficiently replicates and is immunostimulatory in vivo in nonhuman primate species","volume":"11","author":"DS Yee","year":"2025","journal-title":"Sci Adv"},{"issue":"2","key":"pntd.0014642.ref006","doi-asserted-by":"crossref","first-page":"100177","DOI":"10.1016\/j.imj.2025.100177","article-title":"Mysterious Oropouche virus: transmission, symptoms, and control","volume":"4","author":"S Porwal","year":"2025","journal-title":"Infect Med (Beijing)"},{"issue":"4","key":"pntd.0014642.ref007","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taag023","article-title":"Oropouche virus RNA persistence and antibody kinetics: a multi-specimen, genomic and serological analysis","volume":"33","author":"J Navero Castillejos","year":"2026","journal-title":"J Travel Med"},{"issue":"1","key":"pntd.0014642.ref008","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12985-024-02323-z","article-title":"Development of monoclonal antibodies against oropouche virus and its applicability to immunohistochemical diagnosis","volume":"21","author":"AP Andreolla","year":"2024","journal-title":"Virol J"},{"issue":"5","key":"pntd.0014642.ref009","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1128\/JCM.38.5.1827-1831.2000","article-title":"Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay","volume":"38","author":"AJ Johnson","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"5","key":"pntd.0014642.ref010","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/JCM.38.5.1823-1826.2000","article-title":"Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections","volume":"38","author":"DA Martin","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"7","key":"pntd.0014642.ref011","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1128\/JCM.39.7.2445-2452.2001","article-title":"Diagnosis of Oropouche virus infection using a recombinant nucleocapsid protein-based enzyme immunoassay","volume":"39","author":"MF Saeed","year":"2001","journal-title":"J Clin Microbiol"},{"key":"pntd.0014642.ref012","doi-asserted-by":"crossref","first-page":"113976","DOI":"10.1016\/j.jviromet.2020.113976","article-title":"Evaluation of immunoglobulin M-specific capture enzyme-linked immunosorbent assays and commercial tests for flaviviruses diagnosis by a National Reference Laboratory","volume":"286","author":"DF Henriques","year":"2020","journal-title":"J Virol Methods"},{"issue":"4","key":"pntd.0014642.ref013","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s41591-026-04221-z","article-title":"Transmission dynamics of Oropouche virus in Latin America and the Caribbean","volume":"32","author":"ER Manuli","year":"2026","journal-title":"Nat Med"},{"key":"pntd.0014642.ref014","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/srep05885","article-title":"A tool kit for rapid cloning and expression of recombinant antibodies","volume":"4","author":"TS Dodev","year":"2014","journal-title":"Sci Rep"},{"issue":"3","key":"pntd.0014642.ref015","first-page":"544","article-title":"Use of immunoglobulin m cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States","volume":"9","author":"DA Martin","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"12","key":"pntd.0014642.ref016","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1128\/CVI.05269-11","article-title":"Development of a human-murine chimeric immunoglobulin M for use in the serological detection of human alphavirus antibodies","volume":"18","author":"BA Thibodeaux","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"pntd.0014642.ref017","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1128\/CVI.00354-08","article-title":"Development of a human-murine chimeric immunoglobulin M antibody for use in the serological detection of human flavivirus antibodies","volume":"16","author":"BA Thibodeaux","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"pntd.0014642.ref018","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4269\/ajtmh.24-0360","article-title":"Development of a diagnostic IgM antibody capture ELISA for detection of anti-cache valley virus human IgM","volume":"112","author":"C Goodman","year":"2024","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"pntd.0014642.ref019","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01966-23","article-title":"Characterization of a monoclonal antibody specific to California serogroup orthobunyaviruses and development as a chimeric immunoglobulin M-positive control in human diagnostics","volume":"11","author":"JA Powers","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"1","key":"pntd.0014642.ref020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1099\/0022-1317-22-1-21","article-title":"Comparative electrophoretic analysis of the virus proteins of four rhabdoviruses","volume":"22","author":"JF Obijeski","year":"1974","journal-title":"J Gen Virol"},{"issue":"3","key":"pntd.0014642.ref021","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/AAC.44.3.688-692.2000","article-title":"A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates","volume":"44","author":"ML Landry","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pntd.0014642.ref022","doi-asserted-by":"crossref","first-page":"7733","DOI":"10.1038\/s41467-022-35456-2","article-title":"Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones","volume":"13","author":"NS Lima","year":"2022","journal-title":"Nat Commun"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0014642","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:59:03Z","timestamp":1786730343000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014642"}},"subtitle":[],"editor":[{"given":"Daniel","family":"Limonta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0014642","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}